The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics ...
Up to 50 transplant patients will receive a genetically modified pig kidney in a clinical trial that will launch this summer ...
Another patient has received a transplant with a genetically modified pig kidney. Tim Andrews, a 66-year-old who lives in ...
A New Hampshire man fought for the chance at a pig kidney transplant, spending months getting into ... year survival is about ...
A team at Massachusetts General Hospital led by Harvard Medical School physician-scientists has for the second time ...
On Friday, doctors at Massachusetts General Hospital announced that a 66-year-old New Hampshire man had successfully received ...
It was the fourth pig kidney transplant in the United States, and the first of three that will be done at Mass General as ...
The recipient was Tim Andrews, a 66-year-old New Hampshire resident who had end-stage kidney disease and was on dialysis for ...
For the second time in less than a year, doctors at Massachusetts General Hospital have transplanted a genetically-edited pig ...
General Transplant Center. In the time since MGH’s xenotransplant last year, three other pig-to-human kidney xenotransplants have been performed, including one at NYU Langone Health in New York ...
With more than 550,000 Americans suffering from kidney failure and nearly 100,000 on the transplant ... Therapeutics’ pigs have undergone 10 gene edits, including adding six human genes and ...
While the company and transplant surgeons initially planned on using pig hearts as a bridge for patients waiting for human hearts—for anywhere from 100-200 days—the baboons have survived for ...